Drugs / Washed Microbiota Transplantation
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06030752 | Sep 2023 → Apr 2027 expected | autism spectrum disorder | The Second Hospital of Nanjing Medical University | Recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06372184 | Jun 2024 → Jun 2029 expected | allergic rhinitis | The Second Hospital of Nanjing Medical University | Not yet recruiting | No outcome recorded |
| — | NCT06350448 | May 2024 → May 2029 expected | rhinitis | The Second Hospital of Nanjing Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Washed Microbiota Transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06350448 ↗ |
| Route | Other | “The prepared microbiota suspension was infused into the participates' lower gut.” NCT06030752 ↗ |